Dark | Light
# ALX Oncology Holdings Inc (ALXO)

ALXO hits 52-week and all-time highs driven by massive social media buzz and positive sentiment. Recent posts highlight significant stock offerings and insider buying activity.

### About ALX Oncology Holdings Inc
ALX Oncology Holdings Inc. is a biotechnology company focused on developing and commercializing targeted immunotherapies for cancer.  
ALX Oncology Holdings Inc uses the ticker $ALXO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- ALX Oncology Holdings Inc (ALXO) social dominance hit [------] which is 136% higher than it's daily average.
- ALX Oncology Holdings Inc (ALXO) social dominance is up 683.33% from the previous month.
- ALX Oncology Holdings Inc (ALXO) sentiment is up 33.33% from the previous week.
- ALX Oncology Holdings Inc (ALXO) engagements is up 313.01% from the previous month.
- ALX Oncology Holdings Inc Price hit a 52-Week high of $2.60 for the hour
- ALX Oncology Holdings Inc Price hit an all time of $2.60 for the hour

### Price: $2.20
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/close.tsv)  
ALXO's price action reaching a 52-week and all-time high is strongly supported by a significant increase in social media mentions, engagements, and overwhelmingly positive sentiment, alongside a major stock offering and insider buying.  

24-Hour: -8.11%
7-Day: 6.51%
30-Day: 88.89%

1-Year High: $2.60 on 2026-02-10  
1-Year Low: $0.406 on 2025-06-27  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/alt_rank.tsv)  
ALX Oncology Holdings Inc (ALXO) is currently AltRank #2,114 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,821  
1-Year High: [-----] on 2026-01-28  
1-Year Low: [---] on 2026-01-31  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +6  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2026-01-30  
1-Year Low: [--] on 2025-05-09  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [------] +37%  
[--] Month: [------] +313%  
[--] Months: [-------] -6.90%  
[--] Year: [---------] +13%  
1-Year High: [-------] on 2025-03-06  
1-Year Low: [--] on 2026-01-04  

Engagements by network (24h):
YouTube: [--]
Reddit: [--]
News: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +6.10%  
1-Year High: [---] on 2025-06-26  
1-Year Low: [--] on 2026-01-04  

Mentions by network (24h):
YouTube: [--]
Reddit: [--]
News: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning ALX Oncology Holdings Inc (ALXO) in the last [--] hours which is down 41% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +7%  
1-Year High: [---] on 2025-06-26  
1-Year Low: [--] on 2026-01-04  

The most influential creators that mention ALX Oncology Holdings Inc in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@goldchart2](/creator/twitter/goldchart2)           | [--]    | [---]       | [--]    | [---]         |
| [@DSAkdag](/creator/twitter/DSAkdag)                 | [--]    | [------]    | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [---]         |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [---]         |
| [@zohmbastic](/creator/twitter/zohmbastic)           | [--]    | [------]    | [--]     | [--]          |
| [@EventHold](/creator/twitter/EventHold)             | [--]    | [--]        | [--]     | [--]          |
| [@BOSSTRADING0](/creator/twitter/BOSSTRADING0)       | [--]    | [-----]     | [--]     | [--]          |
| [@Gonvelgado](/creator/twitter/Gonvelgado)           | [--]    | [---]       | [--]     | [--]           |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | [--]    | [-----]     | [--]     | [--]           |
| [@AlxOncology](/creator/twitter/AlxOncology)         | [--]   | [---]       | [--]     | [--]           |

[View More](/list/creators/$alxo/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 91%  
[--] Week: 100% +25%  
[--] Month: 100% no change  
[--] Months: 100% +24%  
[--] Year: 100% no change  
1-Year High: 100% on 2025-02-15  
1-Year Low: 20% on 2025-09-06  

Most Supportive Themes:
- Galaxy Score Surge: (40%) The Galaxy Score has seen a significant increase of 164.29% from the previous month, indicating a strong positive shift in overall social and market metrics.
- Increased Social Media Activity: (35%) Posts related to ALX Oncology Holdings Inc. have surged by 281.82% in the past week, suggesting a heightened level of discussion and interest.
- Positive Sentiment: (25%) The sentiment surrounding ALX Oncology Holdings Inc. is at a perfect 100%, indicating overwhelmingly positive discussions among social media users.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.00621%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/social_dominance.tsv)  
Current Value: 0.00621%  
Daily Average: 0.00596%  
[--] Week: 0.00641% +0.00381%  
[--] Month: 0.014% +0.012%  
[--] Months: 0.014% +0.0014%  
[--] Year: 0.014% +0.007%  
1-Year High: 0.061% on 2025-06-26  
1-Year Low: 0.0002% on 2026-01-04  
  
  
### Market Dominance: 0.0003283516768671741%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/market_dominance.tsv)  
Current Value: 0.0003283516768671741%  
Daily Average: 0%  
1-Year High: 0.014% on 2026-02-10  
1-Year Low: 0.00033% on 2026-02-14  
  
  
### Market Cap: $289,945,620
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$alxo/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$alxo/time-series/market_cap.tsv)  
Current Value: $289,945,620  
Daily Average: $183,678,369  
[--] Week: $289,945,620 +8.30%  
[--] Month: $289,945,620 +342%  
1-Year High: $334,552,638 on 2026-02-10  
1-Year Low: $63,435,061 on 2026-01-16  

### Top ALX Oncology Holdings Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 01/30/26 📈 $TRAW 15% Enrollment of Ratutrelvir Clinical Study $PLX 13% Positive CHMP Opinion for Elfabrio $LSTA 12% Termination License Agreement for Certepetide $ALXO 11% CD47 Expression Predicts Evorpacept Response $SRPT 8% Positive EMBARK Results for ELEVIDYS 📉 $QNCX -92% Safety data from long-term treatment $CALC -76% Discontinuation Ph2 KOURAGE Trial $GUTS -68% Durable Weight Maintenance with Revita $CRDF -32% Update on Onvansertib trial $JUNS -23% Expands Nugevia Market for GLP-1 See image below."  
[X Link](https://x.com/BiopharmIQ/status/2017606647355724064) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-01-31T14:31Z 28.9K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

ALX Oncology Holdings Inc (ALXO)

ALXO hits 52-week and all-time highs driven by massive social media buzz and positive sentiment. Recent posts highlight significant stock offerings and insider buying activity.

About ALX Oncology Holdings Inc

ALX Oncology Holdings Inc. is a biotechnology company focused on developing and commercializing targeted immunotherapies for cancer.
ALX Oncology Holdings Inc uses the ticker $ALXO for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • ALX Oncology Holdings Inc (ALXO) social dominance hit [------] which is 136% higher than it's daily average.
  • ALX Oncology Holdings Inc (ALXO) social dominance is up 683.33% from the previous month.
  • ALX Oncology Holdings Inc (ALXO) sentiment is up 33.33% from the previous week.
  • ALX Oncology Holdings Inc (ALXO) engagements is up 313.01% from the previous month.
  • ALX Oncology Holdings Inc Price hit a 52-Week high of $2.60 for the hour
  • ALX Oncology Holdings Inc Price hit an all time of $2.60 for the hour

Price: $2.20

Price Line Chart
Price 24-Hour Time-Series Raw Data
ALXO's price action reaching a 52-week and all-time high is strongly supported by a significant increase in social media mentions, engagements, and overwhelmingly positive sentiment, alongside a major stock offering and insider buying.

24-Hour: -8.11% 7-Day: 6.51% 30-Day: 88.89%

1-Year High: $2.60 on 2026-02-10
1-Year Low: $0.406 on 2025-06-27

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
ALX Oncology Holdings Inc (ALXO) is currently AltRank #2,114 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +1,821
1-Year High: [-----] on 2026-01-28
1-Year Low: [---] on 2026-01-31

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +6
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-01-30
1-Year Low: [--] on 2025-05-09

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] +37%
[--] Month: [------] +313%
[--] Months: [-------] -6.90%
[--] Year: [---------] +13%
1-Year High: [-------] on 2025-03-06
1-Year Low: [--] on 2026-01-04

Engagements by network (24h): YouTube: [--] Reddit: [--] News: [--] X: [---]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +6.10%
1-Year High: [---] on 2025-06-26
1-Year Low: [--] on 2026-01-04

Mentions by network (24h): YouTube: [--] Reddit: [--] News: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning ALX Oncology Holdings Inc (ALXO) in the last [--] hours which is down 41% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +7%
1-Year High: [---] on 2025-06-26
1-Year Low: [--] on 2026-01-04

The most influential creators that mention ALX Oncology Holdings Inc in the last [--] hours

Creator Rank Followers Posts Engagements
@goldchart2 [--] [---] [--] [---]
@DSAkdag [--] [------] [--] [---]
@doepke_michel [--] [------] [--] [---]
@mariostario2019 [--] [--] [--] [---]
@zohmbastic [--] [------] [--] [--]
@EventHold [--] [--] [--] [--]
@BOSSTRADING0 [--] [-----] [--] [--]
@Gonvelgado [--] [---] [--] [--]
@MarcJacksonLA [--] [-----] [--] [--]
@AlxOncology [--] [---] [--] [--]

View More

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 91%
[--] Week: 100% +25%
[--] Month: 100% no change
[--] Months: 100% +24%
[--] Year: 100% no change
1-Year High: 100% on 2025-02-15
1-Year Low: 20% on 2025-09-06

Most Supportive Themes:

  • Galaxy Score Surge: (40%) The Galaxy Score has seen a significant increase of 164.29% from the previous month, indicating a strong positive shift in overall social and market metrics.
  • Increased Social Media Activity: (35%) Posts related to ALX Oncology Holdings Inc. have surged by 281.82% in the past week, suggesting a heightened level of discussion and interest.
  • Positive Sentiment: (25%) The sentiment surrounding ALX Oncology Holdings Inc. is at a perfect 100%, indicating overwhelmingly positive discussions among social media users.

Most Critical Themes:

Social Dominance: 0.00621%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00621%
Daily Average: 0.00596%
[--] Week: 0.00641% +0.00381%
[--] Month: 0.014% +0.012%
[--] Months: 0.014% +0.0014%
[--] Year: 0.014% +0.007%
1-Year High: 0.061% on 2025-06-26
1-Year Low: 0.0002% on 2026-01-04

Market Dominance: 0.0003283516768671741%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0003283516768671741%
Daily Average: 0%
1-Year High: 0.014% on 2026-02-10
1-Year Low: 0.00033% on 2026-02-14

Market Cap: $289,945,620

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $289,945,620
Daily Average: $183,678,369
[--] Week: $289,945,620 +8.30%
[--] Month: $289,945,620 +342%
1-Year High: $334,552,638 on 2026-02-10
1-Year Low: $63,435,061 on 2026-01-16

Top ALX Oncology Holdings Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 01/30/26 📈 $TRAW 15% Enrollment of Ratutrelvir Clinical Study $PLX 13% Positive CHMP Opinion for Elfabrio $LSTA 12% Termination License Agreement for Certepetide $ALXO 11% CD47 Expression Predicts Evorpacept Response $SRPT 8% Positive EMBARK Results for ELEVIDYS 📉 $QNCX -92% Safety data from long-term treatment $CALC -76% Discontinuation Ph2 KOURAGE Trial $GUTS -68% Durable Weight Maintenance with Revita $CRDF -32% Update on Onvansertib trial $JUNS -23% Expands Nugevia Market for GLP-1 See image below."
X Link @BiopharmIQ 2026-01-31T14:31Z 28.9K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

ALX Oncology Holdings Inc (ALXO)
/topic/$alxo